A single-arm multicenter proof-of-concept study of denosumab to treat hypercalcemia of malignancy in patients who are refractory to IV bisphosphonates.
M. I. Hu
Research Funding - Amgen
R. Gucalp
Consultant or Advisory Role - Eisai
K. L. Insogna
No relevant relationships to disclose
I. Glezerman
Research Funding - Amgen
H. G. Bone
Consultant or Advisory Role - Amgen
Honoraria - Amgen
Research Funding - Amgen; Novartis
A. Jaccard
No relevant relationships to disclose
W. Misiorowski
No relevant relationships to disclose
B. W. Yu
No relevant relationships to disclose
H. Yeh
Employment or Leadership Position - Amgen
Stock Ownership - Amgen